Tue, Sep 30, 2014, 9:09 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • johnf50@rocketmail.com johnf50 Mar 12, 2013 6:10 PM Flag

    Barclays conference take away.

    Mostly old news - key components are as follows:

    Vertex has ongoing conversations with potential partners for VX-509 and expects 'data' second half of this year. They already have the data - so my take is that they are planning on having a partnership deal signed by the second half of this year. This is great.

    The consensus of the voting outcomes for the presentation had the following determinations:

    (1) Consensus on Incivek revenue this year is 650 million.

    (2) 74% of the audience believes that the VX-661 data will be positive.

    (3) 60% of the audience believes that the VX-809 data will be positive.

    GLTA - JF

    Sentiment: Strong Buy

112.31-1.59(-1.40%)Sep 30 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Cyber-Ark Software Ltd.
NasdaqGSTue, Sep 30, 2014 4:00 PM EDT
eBay Inc.
NasdaqGSTue, Sep 30, 2014 4:15 PM EDT
BioCryst Pharmaceuticals, Inc.
NasdaqGSTue, Sep 30, 2014 4:15 PM EDT